Perpetual Peptides, Inc.

Perpetual Peptides, Inc. utilizes Symbiont Technology, a proprietary platform that employs uniquely designed plant cells to produce peptides, proteins, and other biomolecules. This system is designed for both in vitro production, where Symbiont plant cells are cultivated in a scalable system for continuous biomolecule output, and in vivo applications, which aim to provide on-host production and delivery of biomolecules to manage plant diseases and pests. The technology is developed to operate without genetic modification of the host plant, offering a versatile approach to biomolecule production. By establishing cell-to-cell connections within a plant's vascular network, the Symbiont cells can continuously deliver specific therapeutic or protective molecules. This platform is intended to transform the bioeconomy and environmental care by providing an efficient, continuous, and sustainable method for creating essential biomolecules.